INVIVO THERAPEUTICS HOLDINGS (NVIV) Forecast, Price Target & Analyst Ratings
NASDAQ:NVIV • US46186M6057
Current stock price
0.3207 USD
-0.17 (-34.28%)
At close:
0.231 USD
-0.09 (-27.97%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVIVO THERAPEUTICS HOLDINGS (NVIV).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $0.32 to mean target of $0.00, Based on 7 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
NVIV was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NVIV.
In the previous month the buy percentage consensus was at a similar level.
NVIV was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | |||||||||
| EBITDA YoY % growth | -21.71M | -23.51M -8.29% | -24.19M -2.89% | -12.68M 47.58% | -11.44M 9.78% | -9.05M 20.89% | -9.86M -8.95% | -10.59M -7.40% | |
| EBIT YoY % growth | -22.4M | -24.06M -7.41% | -24.59M -2.20% | -12.77M 48.07% | -11.5M 9.95% | -9.1M 20.87% | -9.9M -8.79% | -10.65M -7.58% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -14,250.00 | -15,187.50 -6.58% | -8,812.50 41.98% | -882.00 89.99% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A